UK’s NICE Recognizes Cytisine as Key Smoking Cessation Treatment
The 2025 NICE update includes Cytisine as a recommended smoking cessation treatment after its UK launch and a review of clinical evidence.
The 2025 NICE update includes Cytisine as a recommended smoking cessation treatment after its UK launch and a review of clinical evidence.
The antibiotic shows promising antibacterial activity against common NTM strains, with favorable safety profiles, low resistance potential, and high oral bioavailability.
Read MoreA surprising study found that Black patients were less likely to refuse vaccines compared to White patients.
Read MoreImplanted under the skin, the Naloximeter senses dropping oxygen and sends a warning notification to a mobile app. If the user doesn’t engage with the warning message within 30 seconds, the device releases stored naloxone.
Read MoreThe FDA has updated the label for Sanofi’s Flublok influenza vaccine to include safety data from a study of over 48,000 pregnant individuals.
Read MoreThe trial will assess the efficacy of the drug, which has been granted orphan drug designation, when added to the standard of care in preventing or reducing the severity of bronchopulmonary dysplasia.
Read MoreNew sub-analyses show that brensocatib reduced pulmonary exacerbations and slowed lung function decline for most subgroups of patients with non-cystic fibrosis bronchiectasis.
Read MoreCumulative efficacy over three RSV seasons was clinically meaningful at 62.9% against RSV-LRTD after a single dose of the vaccine.Â
Read MoreAstraZeneca’s inhaled anti-inflammatory rescue medication demonstrated significant benefit compared to albuterol in a phase IIIb trial.
Read MoreTopline results demonstrated that the drug was well-tolerated over a 10-day period and achieved consistent plasma levels without the need for ritonavir co-administration.Â
Read MoreThe FDA has approved Dupixent for adults with inadequately controlled COPD and an eosinophilic phenotype.
Read MoreAn NIH-funded analysis suggests higher doses of buprenorphine were associated with lower rates of emergency department visits or use of inpatient services related to behavioral health.
Read MoreResearchers investigated whether transparent capsules in dry powder inhalers improved medication delivery by providing visual feedback to patients.
Read MoreGilead has recalled one lot of Veklury (remdesivir) after confirming the presence of a glass particle in a vial following a customer complaint.
Read MoreA phase III study demonstrated that a single oral dose of Xofluza significantly reduced the spread of influenza within households.
Read MoreThe nasal spray flu vaccine is available for self- or caregiver-administration by prescription for individuals aged 2 to 49.
Read MoreApnimed announced the early completion of enrollment for its phase 3 trial to evaluate the efficacy and safety of AD109 for obstructive sleep apnea.
Read More